BOUNDLESS BIO, INC. Proceeds from Stock Plans
BOUNDLESS BIO, INC. (BOLD) reported Proceeds from Stock Plans of $37.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2026-08-07
- BOUNDLESS BIO, INC. proceeds from stock plans for the quarter ending 2025-12-31 was $24.00K.
- BOUNDLESS BIO, INC. proceeds from stock plans for the quarter ending 2025-09-30 was $0.00.
- BOUNDLESS BIO, INC. proceeds from stock plans for fiscal 2025 was $141.00K, a 28.18% increase from fiscal 2024.
- BOUNDLESS BIO, INC. proceeds from stock plans for fiscal 2024 was $110.00K.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2026-06-30 | $37.00K 10-Q · filed 2026-08-07 | |||
| 2025-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $24.00K derived: sum of 2 quarters · filed 2026-03-09 | $141.00K 10-K · filed 2026-03-09 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $117.00K 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $117.00K 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | $110.00K 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |